Biomaxima (BMX) — Capital Reinvestment Ratio

Latest as of September 2025: 0.30x

Biomaxima (BMX) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (zł1.01 Million) in capital expenditures (zł308.00K). See net asset quality index of Biomaxima to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.30x
Capex / Operating Cash Flow

Operating Cash Flow

zł1.01 Million
PLN

Capital Expenditures

zł308.00K
PLN

Data as of

Sep 2025
Most recent filing

Biomaxima Capital Reinvestment Ratio (2009–2023)

This chart tracks Biomaxima's Capital Reinvestment Ratio across 13 annual periods. Check Biomaxima investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Biomaxima (2009–2023)

Year-by-year Capital Reinvestment Ratio for Biomaxima from 2009 to 2023. For live market cap and broader valuation context, see Biomaxima market capitalisation.

Year Reinvestment Ratio Operating CF (PLN) Capital Expenditures YoY Change
2023 11.36x zł1.59 Million zł18.08 Million ▲ +4160.7%
2022 0.27x zł37.06 Million zł9.88 Million ▼ -43.7%
2020 0.47x zł3.97 Million zł1.88 Million ▲ +42.4%
2019 0.33x zł4.93 Million zł1.64 Million ▼ -96.0%
2018 8.22x zł2.12 Million zł17.42 Million ▲ +597.5%
2017 1.18x zł1.84 Million zł2.17 Million ▲ +350.8%
2016 0.26x zł1.44 Million zł376.12K ▲ +270.3%
2015 0.07x zł2.29 Million zł161.42K ▼ -73.3%
2014 0.26x zł561.02K zł148.50K ▼ -65.6%
2013 0.77x zł1.25 Million zł961.18K ▼ -50.2%
2011 1.54x zł1.83 Million zł2.83 Million ▼ -93.6%
2010 24.11x zł102.89K zł2.48 Million ▲ +678.8%
2009 3.10x zł418.32K zł1.30 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow